Form 4: BIO-KEY International Director Robert Michel Reports Acquisition of Shares Through Stock Incentive Plan

BIO-KEY International, Inc. Director Robert J. Michel reported the acquisition of 6,266 shares of common stock through the company's 2023 Stock Incentive Plan, including restricted stock and shares for board meeting fees.

Summary

• Robert J. Michel, a Director of BIO-KEY International, Inc. (BKYI), reported changes in his beneficial ownership of the company's common stock.
• On May 27, 2025, Mr. Michel acquired 5,000 shares of common stock as a restricted stock grant under the Issuer's 2023 Stock Incentive Plan.
• These 5,000 restricted shares will vest in three equal annual installments on each of the next three anniversaries of the grant date, contingent on Mr. Michel's continued service to the Issuer.
• Additionally, on May 27, 2025, Mr. Michel acquired 1,266 shares of common stock at a price of $0.79 per share, issued as payment for board committee meeting attendance fees under the same 2023 Stock Incentive Plan.
• Following these transactions, Mr. Michel beneficially owns 23,569 shares of common stock directly.
• The reported holdings do not include options to purchase an additional 36 shares.

Sentiment

Score: 6

Explanation: The document reports routine insider compensation, which is generally neutral but can be seen as slightly positive due to the alignment of interests created by equity ownership for a director.

Positives

• The acquisition of shares by a director, even if compensation-related, can signal alignment of interests between management and shareholders.
• The use of a stock incentive plan (2023 Stock Incentive Plan) indicates a structured approach to executive and director compensation, often tied to long-term performance and retention.

Future Outlook

The vesting schedule for the 5,000 restricted shares implies a future commitment from the reporting person to continue employment or service to the Issuer for at least three years from the grant date.

Management Comments

• The transactions reflect the company's compensation practices for its directors, utilizing the 2023 Stock Incentive Plan for both restricted stock grants and payment of board committee meeting attendance fees.

Industry Context

The use of stock incentive plans and restricted stock grants for director compensation is a common practice across various industries, aiming to align the interests of directors with those of shareholders and to incentivize long-term commitment.

Comparison to Industry Standards

• The compensation structure involving restricted stock and stock-based payments for board fees is consistent with standard corporate governance practices for public companies, similar to those observed in technology and software companies of comparable size.
• Many companies, including peers in the identity and access management sector, utilize similar equity-based compensation to attract and retain qualified board members and executives.

Corporate Governance

Related Party Transactions

• The acquisition of shares by Director Robert J. Michel from BIO-KEY International, Inc. constitutes a related party transaction, as it involves a company insider and the company itself.

Stakeholder Impact

• Shareholders: The issuance of new shares for compensation can result in minor dilution, but also aligns the director's interests with long-term shareholder value.
• Employees: The existence of a stock incentive plan suggests a broader framework for incentivizing key personnel, potentially including employees.

Next Steps

• The 5,000 restricted shares will vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to continued service.

Key Dates

Keywords

BIO-KEY International, BKYI, Form 4, Insider Transaction, Stock Grant, Restricted Stock, Director Compensation, Beneficial Ownership, Stock Incentive Plan